Yasushi Shimizu - Concepedia

Author

Yasushi Shimizu

Also Known As

Shimizu, Yasushi, Shunji Takahashi, Y Shimizu, Y. SHIMIZU, Y. Shimizu, YASUSHI SHIMIZU, Yasushi SHIMIZU, Yasushi Shimizu

211

Publications

5.1K

Citations

H-Index

125

Concepts

All Affiliations

Hokkaido University Sapporo Medical University Hokkaido University Hospital National Cancer Center Hospital East Aichi Cancer Center

About

Yasushi Shimizu is an author at Hokkaido University specializing in engineering, medicine, and physics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	11	14	458
2	Medicine	9	9	3.4K
3	Natural Sciences	3	3	118
4	Business	1	1	15
5	Health Sciences	1	1	10

Yasushi Shimizu

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study Barbara Burtness, Kevin J. Harrington, Richard Greil, The Lancet Neoadjuvant TherapyChemotherapy Versus CetuximabMedicinePathologyHead And Neck Cancer	2019	3K
A randomized, open-label, Phase III clinical trial of nivolumab vs. therapy of investigator’s choice in recurrent squamous cell carcinoma of the head and neck: A subanalysis of Asian patients versus the global population in checkmate 141 Naomi Kiyota, Yasuhisa Hasegawa, Shunji Takahashi, Oral Oncology	2017	138
Epigenetic therapy with 3-deazaneplanocin A, an inhibitor of the histone methyltransferase EZH2, inhibits growth of non-small cell lung cancer cells Junko Kikuchi, Taichi Takashina, Ichiro Kinoshita, Lung Cancer Histone ModificationsChromatinOncologyMedicineEpigenetic Change	2012	113
Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance Junko Kikuchi, Ichiro Kinoshita, Yasushi Shimizu, Cancer	2010	96
Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer Junko Kikuchi, Ichiro Kinoshita, Yasushi Shimizu, Lung Cancer Tumor BiologyClinicopathological SignificanceMedicinePathologyBronchial Neoplasm	2010	95
Expression of LGR5, an intestinal stem cell marker, during each stage of colorectal tumorigenesis. Kayoko Takeda, Ichiro Kinoshita, Yasushi Shimizu, PubMed	2011	73
Hydroxylation of benzene catalyzed by selectively site-substituted vanadium(V) heteropolytungstates in the presence of hydrogen peroxide Kenji Nomiya, Hiroto Yanagibayashi, Chika Nozaki, Journal of Molecular Catalysis A Chemical Chemical EngineeringEngineeringSite-substituted VanadiumHeterogeneous CatalysisOrganic Chemistry	1996	71
Expression of Fucosyltransferase 8 Is Associated with an Unfavorable Clinical Outcome in Non-Small Cell Lung Cancers Rio Honma, Ichiro Kinoshita, Eiji Miyoshi, Oncology	2015	61
Combined inhibition of <scp>EZH</scp>2 and histone deacetylases as a potential epigenetic therapy for non‐small‐cell lung cancer cells Taichi Takashina, Ichiro Kinoshita, Junko Kikuchi, Cancer Science	2016	61
Statistical-acoustics models of energy decay in systems of coupled rooms and their relation to geometrical acoustics Jason E. Summers, Rendell R. Torres, Yasushi Shimizu The Journal of the Acoustical Society of America AeroacousticsEngineeringImproved Statistical-acoustics ModelPhysical AcousticStatistical-acoustics Models	2004	60

Page 1